TLR9 and cutaneous leishmaniasis: Previous in vivo studies using mouse models of visceral and cutaneous leishmaniasis have reported that, during the early phase of infection, DCs can activate NK cells in a TLR9 and IL-12-dependent manner, thereby limiting parasite spread and preventing disease establishment [15, 23].